8
Fight Illicit Pill Presses Act
10/3/2025, 4:23 AM
Summary of Bill S 2870
Congressional Summary of S 2870
Fight Illicit Pill Presses Act
This bill broadens the scope of pill machines that are subject to regulation under the Controlled Substances Act (CSA). The bill also requires regulated machines to have serial numbers and imposes criminal penalties for conduct involving the removal of serial numbers or the transportation of regulated machines knowing the serial numbers have been removed.
Currently, the CSA requires persons who manufacture, distribute, import, export, or purchase certain regulated machines to keep records of and report on transactions involving the machines. Currently, the term regulated machines includes tableting machines and encapsulating machines.
This bill requires persons who sell or deliver regulated machines to comply with the CSA's recordkeeping and reporting requirements, in addition to persons who manufacture, distribute, import, export, or purchase them.
The bill also expands regulated machines, for which transactions must be recorded and reported, to include critical parts of tableting and encapsulating machines such as dies used to mold pills and punches used to imprint markings and logos onto pills.
The bill requires serial numbers to be permanently affixed to encapsulating machines, tableting machines, and critical parts of tableting and encapsulating machines.
Finally, the bill prohibits, subject to criminal penalties, the (1) removal, alteration, or obliteration of any serial number affixed to a tableting machine, encapsulating machine, or a critical part; or (2) transportation, shipment, receipt, possession, distribution, delivery, sale, import, or export of any tableting machine, encapsulating machine, or critical part knowing the serial number has been removed, altered, or obliterated.
Read the Full Bill
Current Status of Bill S 2870
Bipartisan Support of Bill S 2870
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
12Democrat Cosponsors
7Republican Cosponsors
5Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2870
Primary Policy Focus
Alternate Title(s) of Bill S 2870
Comments

Baker Cummings
10 months ago
This bill bad for me. It benefits big pharma.





